The Rheumatology Podcast

The Rheumatology Podcast

By Oxford University PressMedicine
Download on the App Store

The Rheumatology Podcast episodes

  • BSR Guideline for the Management of Gout
    Prof Jaap van Laar talks to Dr Ed Roddy, Keele University, UK, about the recently published update of the BSR guideline for the management of gout. Dr Roddy explains the need for this update due to the development of new drugs to treat gout as well as epidemiological studies showing an increase of incidence and prevalence but a lack of improvement in the treatment of gout. The guideline highlights the importance of increasing both GP and patient education. It also suggests a paradigm shift in the treatment to using urate lowering drugs in all patients and not waiting until a chronic condition develops.
    5 min
  • Rheumatology Podcast - Lars Erik Kristensen
    Professor Jaap van Laar interviews Dr Lars Eric Kristensen, Parker Institute, Copenhagen, Denmark, regarding his paper on the link between obesity and biological use in psoriatic arthritis. The observational cohort study uses nationwide data from the DANBIO and ICEBIO registries.
    6 min
  • Rheumatology Podcast - Lars Erik Kristensen
    Professor Jaap van Laar interviews Dr Lars Eric Kristensen, Parker Institute, Copenhagen, Denmark, regarding his paper on the link between obesity and biological use in psoriatic arthritis. The observational cohort study uses nationwide data from the DANBIO and ICEBIO registries.
    6 min
  • Rheumatology Podcast - Lars Erik Kristensen
    Professor Jaap van Laar interviews Dr Lars Eric Kristensen, Parker Institute, Copenhagen, Denmark, regarding his paper on the link between obesity and biological use in psoriatic arthritis. The observational cohort study uses nationwide data from the DANBIO and ICEBIO registries.
    6 min
  • Rheumatology Podcast - Bernard Lauwerys
    Professor Jaap van Laar interviews Dr Bernard Lauwerys, UCLouvain, Belgium, regarding his study on interferon α kinoids and their effect on B cell activation transcripts in Lupus. The paper discusses the link between the blockade of interferon α and the decreased expression of genes involved in B cell activation.
    6 min
  • Rheumatology Podcast - Astrid van Tubergen
    Professor Jaap van Laar interviews Dr Astrid van Tubergen, Maastricht University, The Netherlands, regarding her study on gender differences in ankylosing spondylitis. The paper focuses on clinical and radiographic outcomes, using 12 years of follow-up data from the OASIS cohort.
    5 min
  • Rheumatology Podcast - Astrid van Tubergen
    Professor Jaap van Laar interviews Dr Astrid van Tubergen, Maastricht University, The Netherlands, regarding her study on gender differences in ankylosing spondylitis. The paper focuses on clinical and radiographic outcomes, using 12 years of follow-up data from the OASIS cohort.
    5 min
  • RA patient access to DMARDs in Norway
    Dr James Galloway and Dr Samantha Hider, Keele University, UK discuss a paper by Polina Putrik et al. which looked at access to DMARDs. They discuss the findings of the paper which demonstrated that older patients with low levels of education have less access to DMARDs. They also explore the possible implications of these findings on the daily practice of rheumatologists and the importance of looking at health literacy of patients in practice.
    6 min
  • RA patient access to DMARDs in Norway
    Dr James Galloway and Dr Samantha Hider, Keele University, UK discuss a paper by Polina Putrik et al. which looked at access to DMARDs. They discuss the findings of the paper which demonstrated that older patients with low levels of education have less access to DMARDs. They also explore the possible implications of these findings on the daily practice of rheumatologists and the importance of looking at health literacy of patients in practice.
    6 min
  • Treating IgG4-related disease with rituximab
    Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients after treatment. They discuss the potential implications for future treatment, drawbacks of the study and possible future research directions for the disease.
    8 min

About The Rheumatology Podcast

From the publisher's feed

Rheumatology provides free podcast interviews with experts in the field on key topics.